Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1.62p
   
  • Change Today:
      0.040p
  • 52 Week High: 5.90
  • 52 Week Low: 1.09
  • Currency: UK Pounds
  • Shares Issued: 499.72m
  • Volume: 474,048
  • Market Cap: £8.10m
  • RiskGrade: 328

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £24,113
Lisa Baderoon 583,963 £9,460
Tim Franklin 525,000 £8,505

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 64,932,129 £1,051,900
Luca & Associates AG 22,000,000 £356,400
Invesco Ltd 17,872,341 £289,532
Aviva Investors Global 11,285,180 £182,820
Alora Pharmaceuticals LLC 10,909,091 £176,727
M&G Investments 7,600,000 £123,120
Prudential plc 7,600,000 £123,120
Capital Income Builder 4,870,367 £78,900
Dr R Zimmer 4,551,553 £73,735
Odey Asset Management 3,433,319 £55,620
Rhone Trustees (Switzerland) SA 3,386,000 £54,853
Pictet Overseas Trust Corporation Limited 3,287,500 £53,258

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 1.62p
Change Today 0.040p
% Change 2.53 %
52 Week High 5.90
52 Week Low 1.09
Volume 474,048
Shares Issued 499.72m
Market Cap £8.10m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.54% below the market average29.54% below the market average29.54% below the market average29.54% below the market average29.54% below the market average
25.58% above the sector average25.58% above the sector average25.58% above the sector average25.58% above the sector average25.58% above the sector average
Price Trend
60.61% below the market average60.61% below the market average60.61% below the market average60.61% below the market average60.61% below the market average
28.89% below the sector average28.89% below the sector average28.89% below the sector average28.89% below the sector average28.89% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 11-Aug-2025

Time Volume / Share Price
12:41 100 @ 1.60p
12:38 200 @ 1.62p
12:38 98,604 @ 1.57p
12:26 30,976 @ 1.60p
12:04 22,000 @ 1.62p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page